Liraglutide as add-on to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes: a 26-week, randomised, double-blind, placebo-controlled trial

被引：0
|
作者：
Rea, R. [1 ]
Blonde, L. [2 ]
Belousova, L. [3 ]
Fainberg, U. [4 ]
Garcia-Hernandez, P. A. [5 ]
Jain, S. M. [6 ]
Kaltoft, M. S. [4 ]
Mosenzon, O. [7 ]
Nafach, J. [8 ]
Palle, M. S. [4 ]
机构：
[1] Univ Fed Parana, Endocrinol & Metab Serv SEMPR, Curitiba, Parana, Brazil
[2] Ochsner Med Ctr, New Orleans, LA USA
[3] Almazov Natl Med Res Ctr, St Petersburg, Russia
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ Hosp, Serv Endocrinol, Monterrey, Mexico
[6] TOTALL Diabet Hormone Inst, Indore, Madhya Pradesh, India
[7] Hadassah Hebrew Univ Hosp, Jerusalem, Israel
[8] Dubai Hlth Author, Dubai Diabet Ctr, Dubai, U Arab Emirates
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S371 / S372
页数：2
相关论文
共 50 条
  • [21] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
    Wenying Yang
    Dalong Zhu
    Shenglian Gan
    Xiaolin Dong
    Junping Su
    Wenhui Li
    Hongwei Jiang
    Wenjuan Zhao
    Minxiu Yao
    Weihong Song
    Yibing Lu
    Xiuzhen Zhang
    Huifang Li
    Guixia Wang
    Wei Qiu
    Guoyue Yuan
    Jianhua Ma
    Wei Li
    Ziling Li
    Xiaoyue Wang
    Jiao’e Zeng
    Zhou Yang
    Jingdong Liu
    Yongqian Liang
    Song Lu
    Huili Zhang
    Hui Liu
    Ping Liu
    Kuanlu Fan
    Xiaozhen Jiang
    Yufeng Li
    Qing Su
    Tao Ning
    Huiwen Tan
    Zhenmei An
    Zhaoshun Jiang
    Lijun Liu
    Zunhai Zhou
    Qiu Zhang
    Xuefeng Li
    Zhongyan Shan
    Yaoming Xue
    Hong Mao
    Lixin Shi
    Shandong Ye
    Xiaomei Zhang
    Jiao Sun
    Ping Li
    Tao Yang
    Feng Li
    [J]. Nature Medicine, 2022, 28 : 974 - 981
  • [22] A Randomized, Double-Blind, Placebo-Controlled Study for Diacerein in Patients with Inadequately Controlled Type 2 Diabetes Mellitus
    Pei, Dee
    Huang, Chien-Ning
    Chen, Ching-Chu
    Hsia, Te-Lin
    Lu, Wei-Shu
    Lin, Yi-Yin
    Ku, M. Sherry
    [J]. DIABETES, 2011, 60 : A84 - A85
  • [23] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
    Afshar, H.
    Roohafza, H.
    Mousavi, G.
    Golchin, S.
    Toghianifar, N.
    Sadeghi, M.
    Talaei, M.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
  • [24] Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial
    Chen, Yingli
    Liu, Xiaomin
    Li, Quanmin
    Ma, Jianhua
    Lv, Xiaofeng
    Guo, Lixin
    Wang, Changjiang
    Shi, Yongquan
    Li, Yanbing
    Johnsson, Eva
    Wang, Mei
    Zhao, June
    Ji, Linong
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1044 - 1049
  • [25] A randomized, double-blind placebo-controlled add-on trial to assess the efficacy, safety, and anti-atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus
    Karizi, Sahar rajabzadeh
    Armanmehr, Fatemeh
    Azadi, Hamideh Ghodrati
    Zahroodi, Hojjat Shadman
    Ghalibaf, AmirAli Moodi
    Bazzaz, Bibi Sedigheh Fazly
    Abbaspour, Mohammadreza
    Boskabadi, Javad
    Eslami, Saeid
    Taherzadeh, Zhila
    [J]. PHYTOTHERAPY RESEARCH, 2023, 37 (04) : 1435 - 1448
  • [26] Double-Blind, Placebo-Controlled, Randomised Trial to Assess the Effect of Liraglutide on Ectopic Fat Accumulation in Type 2 Diabetes Mellitus Patients
    Bizino, Maurice B.
    Jazet, Ingrid M.
    Lamb, Hildo J.
    Smit, Jan W.
    [J]. DIABETES, 2017, 66 : A63 - A64
  • [27] Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
    Nauck, Michael
    Rizzo, Manfredi
    Johnson, Andrew
    Bosch-Traberg, Heidrun
    Madsen, Jesper
    Cariou, Bertrand
    [J]. DIABETES CARE, 2016, 39 (09) : 1501 - 1509
  • [28] Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
    Barnett, Anthony H.
    Huisman, Holger
    Jones, Russell
    von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    [J]. LANCET, 2013, 382 (9902): : 1413 - 1423
  • [29] The add-on effect of SGLT2 inhibitor or thiazolidinedione in patients with type 2 diabetes inadequately controlled with triple oral antidiabetics
    Kim, H.
    Kim, Y. -E.
    Lee, S.
    Bae, J.
    Lee, M.
    Huh, J.
    Lee, B. -W.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S270 - S270
  • [30] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY
    OVERWEG, J
    BINNIE, CD
    MEIJER, JWA
    MEINARDI, H
    NUIJTEN, STM
    SCHMALTZ, S
    WAUQUIER, A
    [J]. EPILEPSIA, 1984, 25 (02) : 217 - 222
12345